Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
about
Recent advances in understanding Type 1 DiabetesDefining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportEnvironmental risk factors for type 1 diabetesCapillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da studyType 1 diabetes mellitus.Genetics and its potential to improve type 1 diabetes care.HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionTargeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.Challenges in diagnosis and management of diabetes in the young.Early prediction of autoimmune (type 1) diabetes.Presence of diabetes autoantigens in extracellular vesicles derived from human islets.Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity.Prognostic Classification Factors Associated With Development of Multiple Autoantibodies, Dysglycemia, and Type 1 Diabetes-A Recursive Partitioning Analysis.Follicular Helper T Cells in Autoimmunity.miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity.Islet Autoantibody Measurements from Dried Blood Spots on Filter Paper Strongly Correlate to Serum Levels.Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.Type 1 Diabetes--Reaping the Rewards of a Targeted Research Investment.Strategies for clinical trials in type 1 diabetesFlexible Bayesian additive joint models with an application to type 1 diabetes research.Childhood adiposity and risk of type 1 diabetes: A Mendelian randomization study.Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes.Increasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests.Systemic antimicrobials adjuvant to periodontal therapy in diabetic subjects: a meta-analysis.Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.B cell-targeted immunotherapy for type 1 diabetes: What can make it work?Beta-cell specific autoantibodies: Are they just an indicator of type 1 diabetes?Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?Current and future efforts toward the prevention of type 1 diabetes.The clinical potential of low-level C-peptide secretion.Dysregulation of glucose metabolism in preclinical type 1 diabetes.JDRF's vision and strategy for prevention of type 1 diabetes.Biomarkers of β-Cell Stress and Death in Type 1 Diabetes.Diabetes mellitus in childhood: an emerging condition in the 21st century.Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.Longitudinal monitoring of gene expression in ultra-low-volume blood samples self-collected at home.Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
P2860
Q26766139-23977B52-60C6-4BE8-8386-67ED59810B3DQ27687598-4B85EE56-DA1E-4072-BFBF-33743063F183Q28276366-151B94D4-B39F-4E31-9093-7D2997CF4DC7Q28602447-79F34111-286D-4F4A-98BB-42930FA6EEF4Q30235021-5464080F-1F76-4709-A752-509077B4F2E5Q30252400-BBCE3563-8AD7-4F9E-837F-901FDD5CDF01Q30732418-7F7D4986-2D3A-4D25-A211-5FFC11BC1211Q33739020-0746052C-CEC3-4112-987F-2F505BE9146BQ33801559-C80DB169-A648-41F7-83E0-8B1C55C9A377Q33854613-62CF2D8F-1228-4592-988D-AA72281D5BB8Q33890308-6F6FDF0F-C4CC-48C5-9B01-1E9C77DA9767Q33916508-1C6CC459-9B95-402C-BAAB-E9362E799C46Q36025138-D1E1CFC3-3801-43C7-AED2-803BF66C816AQ36057301-F7BB6E5F-8D84-45D7-B6D6-E96E353A962FQ36176908-D2D0692F-B52E-4BE1-ABAA-60AFF70A25B9Q36192718-EFC54426-771E-4457-82DE-9C5CDE39A93EQ36209699-4F968C33-B5BB-4DBC-BC06-8CC318C13C12Q36926214-AAA6FFF3-3A27-48A9-BB6E-571852996BFCQ36995370-28D5E995-D354-4CC9-847B-C40020021C11Q38630657-9FCAB9CE-7D1B-4A16-BF52-6DF3D8CC3FF4Q38649283-0A5CEA85-4504-4DAA-B445-96914A7DA1ECQ38650009-24717870-D6A7-4C75-9053-2737B7480BF8Q38679602-D7F4592A-4197-4C55-B4A6-2DE1901DE6F3Q38704130-7F6D57BC-08FD-4DBB-8CD8-47365A82A880Q38734604-E1B84E6E-7104-4954-95E0-8E1546F47DD6Q38743412-07E0A25D-4A35-4901-9AEA-82B55F64EFA5Q38806457-30BA6DFF-AD61-45E6-B288-8DF0D66FE2A5Q38817783-7BFBA765-6D68-41A9-AC52-62C338CD6246Q38818303-CDFD7050-1BA6-46B7-A4F3-594E1B866106Q38828063-F4AD7DE5-F78A-4618-8417-6500BBEDA229Q38837965-D640541B-535A-49C1-B89B-11EF561FB625Q38842306-35D3F375-FB4C-4174-9843-680CCEBF5831Q38889362-929692C1-EF73-4F33-A427-1724B24D35EFQ38895409-FFE88B1B-393F-4826-9B9F-5AFBD224883AQ38895435-EB23B958-9B58-4BEC-83DF-A0A7C634A6C5Q38931848-F6A0BC5A-0693-49D3-BAA1-44545C8715AAQ39010040-103ADF7B-2C23-47E5-A9BB-D5FF658138DFQ39040207-FB839198-F2ED-495A-A23D-6BC3A5E8FCC6Q39069291-9699B5FD-2879-4647-91CF-40DA1FECEC12Q40088521-4BAAF7D9-135E-401C-80BD-6D8BA58C85D4
P2860
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Staging presymptomatic type 1 ...... American Diabetes Association.
@en
Staging presymptomatic type 1 ...... American Diabetes Association.
@nl
type
label
Staging presymptomatic type 1 ...... American Diabetes Association.
@en
Staging presymptomatic type 1 ...... American Diabetes Association.
@nl
prefLabel
Staging presymptomatic type 1 ...... American Diabetes Association.
@en
Staging presymptomatic type 1 ...... American Diabetes Association.
@nl
P2093
P2860
P356
P1433
P1476
Staging presymptomatic type 1 ...... American Diabetes Association.
@en
P2093
Anette-G Ziegler
Carla J Greenbaum
Desmond A Schatz
Jane L Chiang
Jay M Sosenko
Jay S Skyler
Jeffrey P Krischer
Jessica L Dunne
Kevan C Herold
Marian J Rewers
P2860
P304
P356
10.2337/DC15-1419
P407
P577
2015-10-01T00:00:00Z